ANP32B promotes colorectal cancer cell progression and reduces cell sensitivity to PRAP1 inhibitor through up-regulating HPF1
The aim of this work is to explore the role of ANP32B on CRC development Overall design: RNA-sequencing analysis was performed on RKO cells with ANP32B knockdown or ANP32B WT, then signaling pathway were identified.